CD274 and cancer: Programmed death-ligand 1 (PD-L1) is expressed in approximately 20% of TNBC, and its interactions with PD-1, a transmembrane receptor protein on the surface of cells in the adaptive immune system, induce T cell inhibition and cancer immune system escape [25].